✦ LIBER ✦

Safety of inhaled (Tobi®) and intravenous tobramycin in young children with cystic fibrosis

✍ Scribed by Hennig, Stefanie; McKay, Karen; Vidmar, Suzanna; O'Brien, Katie; Stacey, Sonya; Cheney, Joyce; Wainwright, Claire E.

Book ID: 122104602
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 348 KB
Volume: 13
Category: Article
ISSN: 1569-1993
DOI: 10.1016/j.jcf.2014.01.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nebulisers comparison with inhaled tobra

Nebulisers comparison with inhaled tobramycin in young children with cystic fibrosis

✍ Aurélie Clavel; Audrey Boulaméry; Emmanuelle Bosdure; Caroline Luc; André Lantea 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Long term effects of inhaled tobramycin

Long term effects of inhaled tobramycin (TOBI®) in cystic fibrosis patients

✍ I. Stelmach; A. Korzeniewska-Eksterowicz; T. Ruszczyk-Bilecka; M. Olszowiec-Chle 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

221. Savings in direct medical costs pro

221. Savings in direct medical costs produced by an inhaled solution of tobramycin (Tobi) in children with cystic fibrosis

✍ Jacques LeLorier; Sylvie Perreault; Howard Birnbaum; Paul Greenberg 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 15 KB

Serum tobramycin levels following delive

Serum tobramycin levels following delivery of tobramycin (TOBI®) via eFlow advanced nebuliser in children with cystic fibrosis

✍ E.L. Guy; T.W. Lee; M. Bosomworth; M. Denton; S.P. Conway; K.G. Brownlee 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Serum tobramycin levels following delive

Serum tobramycin levels following delivery of tobramycin (Tobi®) via eFlow® advanced nebuliser in children with cystic fibrosis

✍ E.L. Guy; M. Bosomworth; M. Denton; S.P. Conway; K.G. Brownlee; T.W.R. Lee 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Falsely elevated serum tobramycin concen

Falsely elevated serum tobramycin concentrations in cystic fibrosis patients treated with concurrent intravenous and inhaled tobramycin

✍ Okan Elidemir; Stephanie R. Maciejewski; Christopher M. Oermann 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB 👁 1 views

A recently developed tobramycin preparation for inhalation (TOBIா, Pathogenesis Corp., Seattle, WA) is widely used in CF patients. It is often used in conjunction with intravenous tobramycin. Renal and ototoxicity associated with the use of tobramycin require that serum drug concentrations be monito